SOM BIOTECH Logo (WIPO, 20.07.2022)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke SOM BIOTECH wurde als Bildmarke am 20.07.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Briefe, die eine besondere Form des Schreibens darstellen #Farben #Serie von Briefen, die verschiedene Formen des Schreibens darstellen #Drei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1696738 |
| Registernummer | 018650684 |
| Länder | 
|
| Basismarke |
Nr. 018650684,
14. Juni 2022
|
| Anmeldedatum | 20. Juli 2022 |
| Ablaufdatum | 20. Juli 2032 |
Markeninhaber
Baldiri Reixac, 4
E-08028 Barcelona
ES
E-08028 Barcelona
ES
Markenvertreter
Avenida de Burgos, 16D,
4ª planta Edificio Euromor
ES
Waren und Dienstleistungen
05
Pharmaceuticals; pharmaceutical drugs; medicine;
pharmaceutical preparations for veterinary use;
pharmaceutical preparations for the prevention of disorders
of the nervous system; pharmaceutical preparations for the
prevention of diseases of the nervous system; pharmaceutical
preparations for the treatment of central nervous system
[CNS] diseases; pharmaceutical preparations for treating
metabolic disorders; chemical preparations for medical
purposes; chemical preparations for pharmaceutical purposes;
pharmaceutical agents affecting metabolism; pharmaceutical
preparations for treating malignant tumors; pharmaceutical
preparations for activating cellular function; medicines for
the treatment of cardiovascular and cerebrovascular
diseases; pharmaceutical preparations for the treatment of
Parkinson's disease; pharmaceutical preparations for the
prevention of disorders of the respiratory system;
pharmaceutical preparations for the prevention of diseases
of the respiratory system; pharmaceutical preparations for
the treatment of rare diseases; pharmaceuticals, for use in
the following fields: treatment of hereditary diseases;
pharmaceutical preparations for the treatment of
gastro-intestinal disorders; pharmaceutical products for the
treatment of infectious diseases; pharmaceuticals, for use
in the following fields: treatment of movement disorders;
pharmaceutical preparations for use in oncology;
pharmaceuticals for the treatment of immune system disease;
pharmaceuticals, for use in the following fields: treatment
of skeletal muscular diseases; pharmaceuticals, for use in
the following fields: treatment of hormone disorders;
pharmaceuticals, for use in the following fields: treatment
of skin diseases; pharmaceutical preparations for use in
ophthalmology; pharmaceuticals, for use in the following
fields: treatment of gynaecological diseases;
pharmaceuticals, for use in the following fields: treatment
of haematological diseases; pharmaceuticals, for use in the
following fields: treatment of paediatric diseases; drug
delivery agents; drug detoxifying agents; central nervous
system stimulants; respiratory stimulants; capsules for
medicines; cardiovascular drugs used in treating congestive
heart failure (CHF); preparations for detecting genetic
predispositions for medical purposes; reagents for use in
medical genetic testing; clinical medical reagents; cells
for medical use; tumor suppressing agents; tumour antigens;
biopharmaceuticals for the treatment of cancer
42
Clinical research; biological research; chemical
technological research; scientific research; biomedical
research; research services in the fields of computation
chemistry; medical and pharmacological research services;
pharmaceutical research and development; research and
development of vaccines and medicines; research relating to
molecular sciences; research relating to biotechnology;
genetic research; research and development in the field of
microorganisms and cells; stem cell research; research in
the field of artificial intelligence technology; research in
relation to the following fields: artificial intelligence
technology; pharmaceutical drug development services;
development of pharmaceutical preparations and medicines;
drug discovery services; implementation of preclinical
trials; clinical trials; biotechnology testing; providing
information about the results of clinical trials for
pharmaceutical products; consultancy pertaining to
pharmacology; consultancy relating to research in the field
of pharmacogenetics; consultancy relating to pharmaceutical
research and development; chemistry consultation;
consultancy relating to biotechnology; information on the
subject of scientific research in the field of biochemistry
and biotechnology; analysis in the field of molecular
biology; laboratory analysis in the field of chemistry;
design and development of medical technology; information
technology services for the pharmaceutical and healthcare
industries; design and development of computer software for
use with medical technology; design and development in
relation to the following fields: artificial intelligence
technology; drug repositioning research; drug combination
research
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 05. August 2023 | 2023/32 Gaz | US | Ablehnung |
| 24. April 2023 | 2023/17 Gaz | GB | Ablehnung |
| 20. Juli 2022 | 2022/44 Gaz | EM | Eintragung |
ID: 141696738